Duncan Mc Hale Evelo Biosciences, Inc. (EVLO) insider trading activity

Duncan Mc Hale is Chief Medical Officer of Evelo Biosciences, Inc.. Currently has a direct ownership of 16,984 shares of EVLO, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 3,103 shares (Common Stock) at a price of $0.33 per share, resulting in proceeds of $1,023. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17K

0% 3M change

0% 12M change

Total Value Held $0

Duncan McHale Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Open market or private sale	$1,023 $0.33 p/Share	3,103 Reduced 15.45%	16,984 Common Stock
Nov 07 2023	BUY Exercise of conversion of derivative security	-	6,500 Added 24.45%	20,087 Common Stock
Nov 02 2023	SELL Open market or private sale	$2,261 $0.33 p/Share	6,854 Reduced 33.53%	13,587 Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	-	12,500 Added 37.95%	20,441 Common Stock
Aug 08 2023	SELL Open market or private sale	$32,657 $9.51 p/Share	3,434 Reduced 30.19%	7,941 Common Stock
Aug 07 2023	BUY Exercise of conversion of derivative security	-	6,500 Added 36.36%	11,375 Common Stock
May 08 2023	SELL Open market or private sale	$8,674 $0.13 p/Share	66,730 Reduced 40.63%	97,516 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	130,000 Added 44.18%	164,246 Common Stock
May 27 2022	BUY Open market or private purchase	$49,999 $1.46 p/Share	34,246 Added 50.0%	34,246 Common Stock

Duncan Mc Hale

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVLO shares.

Notify only if

Value

Insider Trading

Get notified when an Evelo Biosciences, Inc. insider buys or sells EVLO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Evelo Biosciences, Inc.

Track Activities on EVLO

Account